Release Date: 15/02/16 08:45 Summary: FY16 Half Year Results ASX Announcement Price Sensitive: No Download Document 140.74KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%